Connect with us

Technology

Eupraxia Pharmaceuticals to Present at 20th ISDE World Congress for Esophageal Diseases

Published

on

VICTORIA, BC, Sept. 19, 2024 /CNW/ – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug delivery for applications with significant unmet need, today announced that the Company will be presenting a poster at the upcoming 20th International Symposium on Digestive Endoscopy (“ISDE”) World Congress for Esophageal Diseases to be held in Edinburgh, Scotland on September 22-24, 2024.

The event is a premier global conference focused on advancing knowledge and collaboration in the field of digestive endoscopy.

Presentation Details:

Paper Number:

265

Presentation Title:

PP02.05 Initial Results from RESOLVE, a Phase 1b Dose-Escalation Study of EP-104GI
(Extended-Release Fluticasone Propionate Intra-Esophageal Injection) for Eosinophilic Esophagitis

Presentation Type:

Poster Presentation

Theme:

Benign Disease

Session Date & Time:

September 23, 2024, from 12:00 PM to 1:45 PM BST (7:00 AM to 8:45 AM ET)

The presentation, which will feature data from cohorts one through four from the RESOLVE trial, will also be available on Eupraxia’s website at:

https://eupraxiapharma.com/our-science/clinical-trials-and-publications/default.aspx.

About Eupraxia Pharmaceuticals Inc.

Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. DiffuSphere™, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The technology is designed to support extended duration of effect and delivery of drugs in a hyper-localized fashion, targeting only the tissues that physicians are wanting to treat. We believe the potential for fewer adverse events may be achieved through the precision targeting and the stable and flat delivery of the active ingredient when using the DiffuSphere™ technology, versus the peaks and troughs seen with more traditional drug delivery methods. The precision of Eupraxia’s DiffuSphere™ technology platform has the potential to augment and transform existing FDA-approved drugs to improve their safety, tolerability, efficacy and duration of effect. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal disease, where Eupraxia currently is developing advanced treatments, to also be applicable in oncology, infectious disease and other critical disease areas.

Eupraxia’s EP-104GI is currently in a Phase 1b/2a trial, the RESOLVE trial, for the treatment of eosinophilic esophagitis (“EoE”). EP-104GI is administered as an injection into the esophageal wall, providing local delivery of drug. This is a unique treatment approach for EoE. Eupraxia also recently completed a Phase 2b clinical trial (SPRINGBOARD) of EP-104IAR for the treatment of pain due to knee osteoarthritis. The trial met its primary endpoint and three of the four secondary endpoints. In addition, Eupraxia is developing a pipeline of later and earlier-stage long-acting formulations. Potential pipeline indications include candidates for other inflammatory joint indications and oncology, each designed to improve on the activity and tolerability of currently approved drugs. For further details about Eupraxia, please visit the Company’s website at: www.eupraxiapharma.com.

Notice Regarding Forward-looking Statements and Information

This news release includes forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “is expected”, “expects”, “suggests”, “scheduled”, “intends”, “contemplates”, “anticipates”, “believes”, “proposes”, “potential” or variations (including negative and grammatical variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements in this news release include statements regarding the details of the Company’s presentation at the upcoming 20th ISDE World Congress for Esophageal Diseases; the Company’s product candidates, including their expected benefits to patients with respect to safety, tolerability; efficacy and duration; the results gathered from studies and trials of Eupraxia’s product candidates; the potential for the Company’s technology to impact the drug delivery process; potential market opportunity for the Company’s products; and potential pipeline indications. Such statements and information are based on the current expectations of Eupraxia’s management, and are based on assumptions, including but not limited to: future research and development plans for the Company proceeding substantially as currently envisioned; industry growth trends, including with respect to projected and actual industry sales; the Company’s ability to obtain positive results from the Company’s research and development activities, including clinical trials; and the Company’s ability to protect patents and proprietary rights. Although Eupraxia’s management believes that the assumptions underlying these statements and information are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this news release may not occur by certain dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting Eupraxia, including, but not limited to: risks and uncertainties related to the Company’s limited operating history; the Company’s novel technology with uncertain market acceptance; if the Company breaches any of the agreements under which it licenses rights to its product candidates or technology from third parties, the Company could lose license rights that are important to its business; the Company’s current license agreement may not provide an adequate remedy for its breach by the licensor; the Company’s technology may not be successful for its intended use; the Company’s future technology will require regulatory approval, which is costly and the Company may not be able to obtain it; the Company may fail to obtain regulatory approvals or only obtain approvals for limited uses or indications; the Company’s clinical trials may fail to demonstrate adequately the safety and efficacy of its product candidates at any stage of clinical development; the Company may be required to suspend or discontinue clinical trials due to side effects or other safety risks; the Company completely relies on third parties to provide supplies and inputs required for its products and services; the Company relies on external contract research organizations to provide clinical and non-clinical research services; the Company may not be able to successfully execute its business strategy; the Company will require additional financing, which may not be available; any therapeutics the Company develops will be subject to extensive, lengthy and uncertain regulatory requirements, which could adversely affect the Company’s ability to obtain regulatory approval in a timely manner, or at all; the impact of health pandemics or epidemics on the Company’s operations; the Company’s restatement of its consolidated financial statements, which may lead to additional risks and uncertainties, including loss of investor confidence and negative impacts on the Company’s common share price; and other risks and uncertainties described in more detail in Eupraxia’s public filings on SEDAR+ (sedarplus.ca) and EDGAR (sec.gov). Although Eupraxia has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements and information, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement or information can be guaranteed. Except as required by applicable securities laws, forward-looking statements and information speak only as of the date on which they are made and Eupraxia undertakes no obligation to publicly update or revise any forward-looking statement or information, whether as a result of new information, future events or otherwise.

View original content to download multimedia:https://www.prnewswire.com/news-releases/eupraxia-pharmaceuticals-to-present-at-20th-isde-world-congress-for-esophageal-diseases-302253679.html

SOURCE Eupraxia Pharmaceuticals Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Huawei Cloud Launches Agentic Infrastructure and CodeArts Agent OBT in Thailand, Accelerating Enterprise AI Innovation

Published

on

By

BANGKOK, July 24, 2026 /PRNewswire/ — Huawei Cloud hosted Huawei Cloud Summit Thailand 2026, bringing together leaders from government, business, industry partners, and the technology community to exchange views on how cloud and AI can support Thailand’s digital economy. During the event, Huawei Cloud announced “Huawei Cloud Agentic Infrastructure: Now Available for Thailand” and officially launched Huawei Cloud CodeArts Agent Open Beta Testing (OBT) in the country.

Mr. Sunny Shang, President of Huawei Cloud APAC, outlined the company’s commitment to working with customers and partners to build an AI-driven digital future for Thailand. Regarding the government’s direction, the Ministry of Digital Economy and Society emphasized the acceleration of digital transformation through national AI policies, public-sector adoption, and stronger public-private collaboration.

The public-sector highlighted how AI can improve government operations and make public services faster and more convenient. NECTEC also presented a Government AI case study covering the development of AI infrastructure and platforms, as well as AI chatbots and intelligent assistants designed to support government officials and improve services for citizens.

Building the Foundation for the Agentic AI Era

Mr. Surasak Wanichwatphibun, CTO of Huawei Cloud Thailand said Huawei Cloud will continue to strengthen its technological capabilities and build a robust computing infrastructure to drive AI innovation across enterprises.

At the center of the announcement is Agentic Infra, a new infrastructure designed specifically for developing and deploying AI agents. It supports efficient token generation, unified scheduling of general-purpose and AI computing resources, continuous learning, and secure and autonomous agent operations.

Mr. Surasak introduced four new features under Agentic Infra:

UnifiedBus-based AI Cluster Service (AICS), which supports highly efficient token generationAgentic Memory Storage Service (AMS), which delivers PB-scale memory storage to address a key bottleneck in agent memory, enabling long-horizon tasks and facilitating continuous learning.AgentSphere, which offers a secure and autonomous runtime environment for AI agentsCCE VolcanoNext, which enables unified scheduling of general-purpose and AI computing resources

CodeArts Agent OBT Launches in Thailand

Another major highlight was the launch of Huawei Cloud CodeArts Agent OBT in Thailand, giving local developers and enterprises an opportunity to experience Huawei Cloud’s coding agent and provide feedback before its wider release.

CodeArts Agent combines IDE functionality, autonomous development capabilities, and coding models. It supports project-level code generation, code completion, R&D knowledge Q&A, and unit test case generation.

The platform also applies Specification-Driven Development (SDD) to help development teams maintain code quality from the requirements stage through to final delivery.

It is worth mentioning that this release also introduces the Agent Team mode, which can automatically form a development team, enabling multiple agents to collaborate concurrently and execute tasks simultaneously.

By reducing repetitive tasks, CodeArts Agent can help developers work more efficiently and allow organizations to bring digital products and services to market faster.

The OBT launch forms part of Huawei Cloud’s efforts to support Thailand’s developer community and make AI-assisted software development more accessible to organizations of different sizes.

Strengthening Security for Enterprise AI

Mr. Surasak also emphasized security, stability, and quality as key priorities for enterprise AI adoption. As cyberattacks become increasingly automated and AI-driven, Huawei Cloud has upgraded its security services in two areas: protecting AI systems and using AI to strengthen cyber defense.

Its model lifecycle security solution covers AI infrastructure, training data, model inference, and agent applications.

For enterprises concerned about data sovereignty and privacy, Huawei Cloud provides dedicated security zones that allow customers to independently manage their encryption keys while preventing platform administrators from accessing customer data. Software-hardware integration and hardware acceleration are also used to maintain encryption performance without compromising service efficiency. Huawei Cloud has also introduced Data Capsule technology, which ensures that data can only be used within authorized environments and automatically becomes invalid if moved outside a designated security zone.

Showcasing AI Use Cases Across Industries

Huawei Cloud Summit Thailand 2026 also featured AI and cloud use cases from organizations in Thailand. These included the development of AI platforms and intelligent assistants for the public sector, the use of AI coding and large language models in banking, and AI-powered learning and skills development platforms for the HR sector.

Huawei Cloud and its partners also shared how ecosystem collaboration can help solve industry challenges and accelerate AI adoption among enterprises.

About Huawei Cloud Thailand

Huawei Cloud Thailand is a leading cloud service provider committed to accelerating Thailand’s digital transformation under the mission of “In Thailand, For Thailand.” According to the latest report from Gartner, Huawei Cloud is ranked No.3 by revenue in Thailand’s Infrastructure as a Service (IaaS) market, solidifying its position as one of the most trusted and fastest-growing international cloud providers in the country.

As the first international public cloud vendor to establish local data centers in Thailand, Huawei Cloud now operates three Availability Zones, ensuring high reliability and low-latency connectivity for local users. Leveraging Huawei’s 30-plus years of expertise in ICT infrastructure, it integrates cutting-edge Artificial Intelligence (AI), Cloud-Native 2.0, and Big Data technologies to empower over 40 government agencies and thousands of enterprises across the Kingdom. By building a robust digital ecosystem and fostering local talent, Huawei Cloud aims to drive Thailand’s “Digital Economy” forward, bringing cloud and intelligence to every corner of the country for a fully connected, intelligent future.

For more information, please visit Huawei Cloud Thailand online at

https://www.huaweicloud.com/intl/th-th/ or follow us on:

https://www.facebook.com/HuaweiCloudTH

https://www.youtube.com/@HuaweiCloudAPAC

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/huawei-cloud-launches-agentic-infrastructure-and-codearts-agent-obt-in-thailand-accelerating-enterprise-ai-innovation-302833957.html

SOURCE Huawei Cloud Thailand

Continue Reading

Technology

Huawei Cloud Launches Agentic Infrastructure and CodeArts Agent OBT in Thailand, Accelerating Enterprise AI Innovation

Published

on

By

BANGKOK, July 24, 2026 /PRNewswire/ — Huawei Cloud hosted Huawei Cloud Summit Thailand 2026, bringing together leaders from government, business, industry partners, and the technology community to exchange views on how cloud and AI can support Thailand’s digital economy. During the event, Huawei Cloud announced “Huawei Cloud Agentic Infrastructure: Now Available for Thailand” and officially launched Huawei Cloud CodeArts Agent Open Beta Testing (OBT) in the country.

Mr. Sunny Shang, President of Huawei Cloud APAC, outlined the company’s commitment to working with customers and partners to build an AI-driven digital future for Thailand. Regarding the government’s direction, the Ministry of Digital Economy and Society emphasized the acceleration of digital transformation through national AI policies, public-sector adoption, and stronger public-private collaboration.

The public-sector highlighted how AI can improve government operations and make public services faster and more convenient. NECTEC also presented a Government AI case study covering the development of AI infrastructure and platforms, as well as AI chatbots and intelligent assistants designed to support government officials and improve services for citizens.

Building the Foundation for the Agentic AI Era

Mr. Surasak Wanichwatphibun, CTO of Huawei Cloud Thailand said Huawei Cloud will continue to strengthen its technological capabilities and build a robust computing infrastructure to drive AI innovation across enterprises.

At the center of the announcement is Agentic Infra, a new infrastructure designed specifically for developing and deploying AI agents. It supports efficient token generation, unified scheduling of general-purpose and AI computing resources, continuous learning, and secure and autonomous agent operations.

Mr. Surasak introduced four new features under Agentic Infra:

UnifiedBus-based AI Cluster Service (AICS), which supports highly efficient token generationAgentic Memory Storage Service (AMS), which delivers PB-scale memory storage to address a key bottleneck in agent memory, enabling long-horizon tasks and facilitating continuous learning.AgentSphere, which offers a secure and autonomous runtime environment for AI agentsCCE VolcanoNext, which enables unified scheduling of general-purpose and AI computing resources

CodeArts Agent OBT Launches in Thailand

Another major highlight was the launch of Huawei Cloud CodeArts Agent OBT in Thailand, giving local developers and enterprises an opportunity to experience Huawei Cloud’s coding agent and provide feedback before its wider release.

CodeArts Agent combines IDE functionality, autonomous development capabilities, and coding models. It supports project-level code generation, code completion, R&D knowledge Q&A, and unit test case generation.

The platform also applies Specification-Driven Development (SDD) to help development teams maintain code quality from the requirements stage through to final delivery.

It is worth mentioning that this release also introduces the Agent Team mode, which can automatically form a development team, enabling multiple agents to collaborate concurrently and execute tasks simultaneously.

By reducing repetitive tasks, CodeArts Agent can help developers work more efficiently and allow organizations to bring digital products and services to market faster.

The OBT launch forms part of Huawei Cloud’s efforts to support Thailand’s developer community and make AI-assisted software development more accessible to organizations of different sizes.

Strengthening Security for Enterprise AI

Mr. Surasak also emphasized security, stability, and quality as key priorities for enterprise AI adoption. As cyberattacks become increasingly automated and AI-driven, Huawei Cloud has upgraded its security services in two areas: protecting AI systems and using AI to strengthen cyber defense.

Its model lifecycle security solution covers AI infrastructure, training data, model inference, and agent applications.

For enterprises concerned about data sovereignty and privacy, Huawei Cloud provides dedicated security zones that allow customers to independently manage their encryption keys while preventing platform administrators from accessing customer data. Software-hardware integration and hardware acceleration are also used to maintain encryption performance without compromising service efficiency. Huawei Cloud has also introduced Data Capsule technology, which ensures that data can only be used within authorized environments and automatically becomes invalid if moved outside a designated security zone.

Showcasing AI Use Cases Across Industries

Huawei Cloud Summit Thailand 2026 also featured AI and cloud use cases from organizations in Thailand. These included the development of AI platforms and intelligent assistants for the public sector, the use of AI coding and large language models in banking, and AI-powered learning and skills development platforms for the HR sector.

Huawei Cloud and its partners also shared how ecosystem collaboration can help solve industry challenges and accelerate AI adoption among enterprises.

About Huawei Cloud Thailand

Huawei Cloud Thailand is a leading cloud service provider committed to accelerating Thailand’s digital transformation under the mission of “In Thailand, For Thailand.” According to the latest report from Gartner, Huawei Cloud is ranked No.3 by revenue in Thailand’s Infrastructure as a Service (IaaS) market, solidifying its position as one of the most trusted and fastest-growing international cloud providers in the country.

As the first international public cloud vendor to establish local data centers in Thailand, Huawei Cloud now operates three Availability Zones, ensuring high reliability and low-latency connectivity for local users. Leveraging Huawei’s 30-plus years of expertise in ICT infrastructure, it integrates cutting-edge Artificial Intelligence (AI), Cloud-Native 2.0, and Big Data technologies to empower over 40 government agencies and thousands of enterprises across the Kingdom. By building a robust digital ecosystem and fostering local talent, Huawei Cloud aims to drive Thailand’s “Digital Economy” forward, bringing cloud and intelligence to every corner of the country for a fully connected, intelligent future.

For more information, please visit Huawei Cloud Thailand online at

https://www.huaweicloud.com/intl/th-th/ or follow us on:

https://www.facebook.com/HuaweiCloudTH

https://www.youtube.com/@HuaweiCloudAPAC

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/huawei-cloud-launches-agentic-infrastructure-and-codearts-agent-obt-in-thailand-accelerating-enterprise-ai-innovation-302833957.html

SOURCE Huawei Cloud Thailand

Continue Reading

Technology

Loomis Interim Report January – June 2026

Published

on

By

STOCKHOLM, July 24, 2026 /PRNewswire/ —

Continued strong growth and record operating margin (EBITA %)

President and CEO Aritz Larrea comments:

“We delivered another very strong quarter reflecting the continued execution of our strategy and the strength of our diversified model. Revenue reached SEK 7.9 billion with a currency-adjusted growth of 9.1 percent. Both segment USA and segment Europe and Latin America contributed to the performance driven by continued strength in our International and Automated Solutions business lines. Operating income (EBITA) exceeded 1 billion SEK and we increased our EBITA margin by more than 1 percentage point year–over–year to 14.0 percent.

Our financial position remains strong. Supported by robust cash flow generation and a solid balance sheet, we continue to invest in long-term growth opportunities, pursue value-creating acquisitions, and maintain our commitment to delivering attractive returns to shareholders.”

Quarter 2, April – June 2026

Revenue for the quarter was SEK 7,891 million (7,407). The currency-adjusted growth was 9.1 percent (4.8), of which organic growth was 6.7 percent (3.8) and acquisitions contributed 2.5 percent (1.0). Including the exchange rate effect, the total growth was 6.5 percent (-3.0).Operating income (EBITA) 1) for the quarter was SEK 1,102 million (944) and the operating margin (EBITA) increased to 14.0 percent (12.7).Operating income (EBIT) before items affecting comparability for the quarter was SEK 1,062 million (882) and operating margin (EBIT) before items affecting comparability was 13.5 percent (11.9).Income before taxes for the quarter was SEK 869 million (664) and profit for the period was SEK 608 million (478).Basic earnings per share for the quarter were SEK 9.09 (7.01) and diluted earnings per share were SEK 9.06 (6.99).Cash flow from operating activities 2) was SEK 683 million (550) in the quarter. The cash flow from operating activities for the rolling twelve months was 95 percent (105) of operating income (EBITA).Net debt in relation to EBITDA was 1.60 times (1.75) in the quarter.Loomis expanded its presence in Latin America through the acquisition of Transportadora del Interior in Argentina and the announced acquisition of Hermes Transportes Blindados in Peru.

1)  Earnings Before Interest, Taxes, Amortization of acquisition-related intangible fixed assets, Acquisition-related costs and revenue and items affecting comparability.
2)  Cash flow from operating activities is exclusive of impact from IFRS 16.

Report presentation today at 10.30 a.m. (CEST)

The report will be presented in a webcast conference today at 10.30 am (CEST) by President and CEO Aritz Larrea and CFO Johan Wilsby.

To follow the webcast, please follow this link.

The presentation materials and a recorded version of the conference will be available on https://www.loomis.com/en/investors/reports-and-presentations/ following the presentation.

For more information, please contact:

Jenny Boström
Head of Sustainability and IR
ir@loomis.com
+46 79 006 45 92

Fredrik Hammarbäck
Media and External Communications Manager
media@loomis.com
+46 76 311 56 29

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/loomis-ab/r/loomis-interim-report-january—june-2026,c4377246

The following files are available for download:

https://mb.cision.com/Main/51/4377246/4201809.pdf

Loomis Interim Report January – June 2026

https://mb.cision.com/Public/51/4377246/940bbe0a24c483c8.pdf

Loomis Interim Report January – June 2026 – press release

 

View original content:https://www.prnewswire.com/news-releases/loomis-interim-report-january–june-2026-302833961.html

SOURCE Loomis AB

Continue Reading

Trending